Studies were undertaken to determine whether PTH-related protein (PTHrP) (107-139) mobilizes [Ca 2ϩ ] i in osteoblastic osteosarcoma UMR 106 cells. , in a manner similar to PTHrP (107-111), induced a rapid [Ca 2ϩ ] i response in these cells that was dose dependent (EC 50 of Ϸ0.1 pM) and more efficient than that of PTHrP (1-36) (EC 50 of Ϸ 1 nM). This effect of PTHrP (107-139) was abrogated by micromolar doses of verapamil or nifedipine. However, it was unaffected by 10 M U73122 (a phospholipase C inhibitor), 100 g/ml heparin (an inositol 1,4,5-trisphosphate receptor inhibitor), or 400 ng/ml pertussis toxin (a G i inhibitor), which inhibited the [Ca 2ϩ ] i response to PTHrP (1-36), or by either 25 nM bisindolylmaleimide I (BIM), a protein kinase (PK) C inhibitor, or 1 M phorbol-12-myristate-13-acetate preincubation (22 h). 
PTHrP (107-111), but neither PTHrP (109 -138) nor PTHrP , abolished this effect of PTHrP (107-139). Both PTHrP (107-139) and PTHrP , added together at submaximal doses, induced a higher [Ca 2ϩ ] i response. Moreover, PTHrP (107-139) increased the efficacy of PTHrP (1-36) on [Ca 2ϩ ] i , but decreased its induced increase in PKA activity in these cells. Verapamil or nifedipine (at 50 M) or 25 nM BIM, but not 25 M adenosine 3Ј,5Ј-cyclic monophosphorothioate, Rp-isomer, a PKA inhibitor, abolished the PTHrP (107-139)-induced increase in interleukin 6 messenger RNA (assessed by RT, followed by PCR) in UMR 106 cells. This peptide also increased c-fos messenger RNA in these cells; an effect inhibited by BIM, but unaffected by either verapamil or EGTA. These findings support the existence of high-affinity receptors for PTHrP (107-139), associated with an in- B ONE CELLS FUNCTION in a complex and dynamic microenvironment in which they must constantly sense and respond to the ambient Ca 2ϩ concentration ([Ca 2ϩ ]). Regulation of Ca 2ϩ entry via activation of various plasma membrane Ca 2ϩ channels is an important signaling pathway in osteoblasts (1) . A variety of agents develop intracellular [Ca 2ϩ ] ( [Ca 2ϩ ] i ) signals in these cells, which occurs as an early event in processes associated with osteoblastic differentiation and bone remodeling (1, 2) . Both mechanosensitive and voltage-sensitive Ca 2ϩ channels are present in osteoblasts (1) . In addition, many stimuli (e.g. PTH) induce not only a Ca 2ϩ influx through these channels but also a Ca 2ϩ release from intracellular stores in these cells (3) (4) (5) (6) (7) (8) . PTH-related protein (PTHrP) was initially isolated from hypercalcemia-associated tumors, but is now known to be produced by many normal tissues, including bone (9) . The N-terminal region of both PTH and PTHrP interacts with the type 1 PTH/PTHrP receptor (PTH1R) cloned in osteoblastic cells, thereby activating both adenylate cyclase and phospholipase (PL) C/[Ca 2ϩ ] i (10) . This receptor is also widely distributed, suggesting that PTHrP acts in an autocrine/ paracrine manner in normal tissues (9) . Multiple PTHrP fragments, including the 1-36 domain, and other poorly characterized C-terminal fragments, seem to be secreted by various cell types (11, 12) . One of these putative fragments, PTHrP (107-139) has recently been shown, both in vitro and in vivo, to affect osteoblastic growth and differentiation (13) (14) (15) (16) (17) (18) . Furthermore, these effects of this fragment are likely to be mediated by its interaction with an unidentified, specific receptor, different from the PTH1R, which might also be present in other bone and nonbone cell types (18 -22) . In the wide majority of these cells, including osteoblastic cells, activation of this putative receptor seems to interact with protein kinase (PK) C activation (13-16, 19 -21) . In addition, a recent report has shown that PTHrP (107-139) induces [Ca 2ϩ ] i transients, but in contrast to either PTHrP (1-34) or PTH (1-34), it does not activate cAMP in rat hippocampal neurons (22) . Interestingly, different bone regulators seem to modulate the induction of various osteoblastic genes through both PKC activation and [Ca 2ϩ ] i signaling (23) (24) (25) . However, the putative role of the latter mechanism associated with the effects of PTHrP (107-139) in osteoblastic cells has not yet been assessed.
The present study was carried out to evaluate the effect of PTHrP (107-139) on [Ca 2ϩ ] i in rat osteoblastic osteosarcoma UMR 106 cells, which respond to this peptide (13, 16) . We have compared this effect of PTHrP (107-139) with that induced by PTHrP (1-36) acting through the PTH1R in these cells (26) . We also assessed whether the effect of PTHrP (107-139) on [Ca 2ϩ ] i might be related to the induction of interleukin 6 (IL-6) and c-fos gene expression in these cells.
Materials and Methods Reagents
Human PTHrP (107-139), pertussis toxin (PTX), fura-2 acetoxymethylester, and 3-isobutyl-1-methylxanthine were from Sigma (St. Louis, MO). Human PTHrP 
Cell culture
UMR 106 cells (ATCC CRL 1661) were seeded on round glass coverslips (12-mm diameter; Menzel, Braunschweig, Germany) at a density of 30,000 cells/coverslip and grown in DMEM with 1 g/liter glucose, 4 mm l-glutamine, 10% FBS, and antibiotics (13) . The cells were incubated in a humidified atmosphere containing 5% CO 2 in air at 37 C for 2 days.
Measurement of cytosolic calcium
We used subconfluent cells, at days 2-4 after seeding, because these cells have been previously shown to exhibit a higher [Ca 2ϩ ] i in the proliferative phase (8, 16) . Cells were plated onto coverslips, and 48 h later adherent cells were loaded with the acetoxymethyl ester of fura-2 (5 m) for 1 h at room temperature in a loading buffer containing 10 mm HEPES, 145 mm NaCl, 5 mm KCl, 1 mm CaCl 2 , 1 mm KH 2 PO 4 , 1 mm MgCl 2 , 5 mm glucose, and 0.1% BSA, adjusted to pH 7.4. After loading, cells were washed three times and resuspended in loading buffer. Fluorescence emission was monitored in a LS-50B spectrofluorimeter (Perkin-Elmer Corp., Norwalk, CT), as described previously (27) . Maximal and minimal fluorescence values were determined by adding 1% Triton X-100 and 10 mm EGTA, respectively. [Ca 2ϩ ] i (nm) was calculated, assuming 225 nm as the dissociation constant (K d ) for Ca 2ϩ -fura-2. All experiments were performed at 37 C.
Measurement of PKA
UMR 106 cells were stimulated with the different agonists in FBSdepleted medium for variable time periods. PKA activity was measured in cell extracts, as described previously (13) . PKA activity was expressed as the ratio of activity in the absence and in the presence of 6.25 m cAMP.
RNA extraction and RT-PCR
Cell total RNA was isolated using guanidinium thiocyanate-phenolchloroform extraction (Tri Reagent; Molecular Research Center, Inc., Cincinnati, OH). Changes in IL-6 levels were assessed by semiquantitative RT-PCR. Total RNA was added to a reaction mixture containing 1.5 mm MgSO 4 , 0.2 mm dNTP, 1 U avian myeloblastosis virus reverse transcriptase, 1 U thermostable DNA polymerase from Thermus flavus (Access RT-PCR System; Promega Corp., Madison, WI), and 1 m of the specific primers: 5Ј-TTCCAGCCAGTTGCCTTCT-3Ј (sense) and 5Ј-TGCTCTGAATGACTCTGGC-3Ј (antisense), corresponding to bases 89 -498 of the rat IL-6 complementary DNA (accession number M26744); or 5Ј-GGGAATTC-GGAGAATCCGAAGGGAAAGG-3Ј (sense), and 5Ј-CCGGATCC-GTGAAGGCCTCCTCAGACTC-3Ј (antisense), corresponding to bases 553-853 in rat-c-fos complementary DNA (accession number X06769). PCR amplification yields 409-bp (IL-6) and 316-bp (c-fos) products. The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase was amplified as a constitutive control (15) .
Preliminary experiments established the linear amplification range for each PCR product. Then, total RNA [200 ng (IL-6); 10 ng (c-fos); 1 ng (glyceraldehyde-3-phosphate dehydrogenase)] was incubated in a reaction mixture (10 l) for 45 min at 48 C, followed by 32-35 cycles of 1 min at 95 C, 1 min at 58 -60 C, and 2 min at 68 C, with a final extension of 7 min at 68 C. A negative control without RNA was usually included in the PCR reaction. Abundance of PCR products was assessed on 2% agarose gels stained with ethidium bromide using DNA markers. To confirm the identity of the PCR products, they were extracted with Wizard PCR prep columns (Promega Corp.) following agarose gel electrophoresis. The extracted PCR products were analyzed by automatic sequencing (373 DNA sequencer; PE Applied Biosystems, Branchburg, NJ).
Statistical analysis
Data are expressed as mean Ϯ sem throughout the text. Statistical significance was determined by either Mann-Whitney test or ANOVA, when appropriate. ] i in UMR 106 cells seems to depend on Ca 2ϩ influx from the extracellular compartment, because the addition of either EGTA (data not shown), verapamil or nifedipine, two l-type calcium channel blockers at micromolar concentrations (28) , abolished this maximal effect triggered by PTHrP (107-139) in these cells (Table 1) . However, treatment with these channel blockers, at 10 nm, did not inhibit the stimulatory effect of PTHrP (107-139) on [Ca 2ϩ ] i in UMR 106 cells (Table 1) . On the contrary, 10 nm of these agents increased [Ca 2ϩ ] i in these cells (Table 1) , consistent with previous findings (29, 30) . On the other hand, 10 m U73122, a PLC inhibitor (31), or 100 g/ml heparin, which inhibits inositol 1,4,5-trisphosphate receptors (32), did not change the effect on [Ca 2ϩ ] i rise triggered by PTHrP (107-139), but abolished this effect induced by PTHrP (1-36) in these cells (Table 2 ). In various cell types, receptor coupling to voltage-dependent Ca 2ϩ channels seems to depend on a PTX-sensitive G protein activation (33 ] i response to PTHrP (107-139), although this pretreatment inhibited this effect induced by PTHrP , in these cells (Table 2) .
Results

PTHrP
Interaction between the effects on [Ca 2ϩ ] i induced by PTHrP (107-139) and PTHP (1-36)
We next sought to determine whether the stimulated [Ca 2ϩ ] i signals induced by each PTHrP peptide were affected by the other peptide in UMR 106 cells. Pretreatment of these cells for at least 5 min with either PTHrP (107-139) or PTHrP , at 100 nm, desensitized the changes in [Ca 2ϩ ] i to a second challenge with the same peptide (Fig. 3, A and C) . On the other hand, the addition of one of these peptides after initial exposure to the other peptide failed to decrease the corresponding induced change in [Ca 2ϩ ] i in UMR 106 cells (Fig. 3, B and D) . Pretreatment with 100 nm PTHrP (7-34), a PTH1R antagonist (34), decreased the effect triggered by PTHrP (1-36), although it did not affect that of PTHrP (107-139), each at 100 nm, on [Ca 2ϩ ] i in these cells (Fig. 4) . Moreover, preincubation with 100 nm PTHrP (107-111), in contrast to PTHrP (109 -138), abolished the maximal effect on [Ca 2ϩ ] i induced by PTHrP (107-139) in UMR 106 cells (Fig. 5) .
Cell stimulation with both PTHrP (107-139) and PTHrP n ϭ 4) (Fig. 2, A (Fig. 7) .
Effect of PTHrP (107-139) on PTHrP (1-36)-stimulated PKA activity in UMR 106 cells
We next determined whether the PKA response to PTHrP (1-36) was also modified by PTHrP (107-139) pretreatment in UMR 106 cells. In agreement with a previous report (13), we found that the latter peptide, at 1 m, had no significant effect on basal PKA activity in these cells, in the absence (data not shown) or presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (Fig. 8) . Nevertheless, preincubation with this peptide for 15 min decreased the maximal increase in PKA activity induced by PTHrP (1-36) in these cells (Fig. 8) . UMR 106 cells on glass coverslips and loaded with fura-2 were stimulated with the different agonists. Heparin and PTX were used at 100 g/ml and 400 ng/ml, respectively. PTHrP (107-139) and 
PTHrP (107-139) STIMULATES Ca 2ϩ IN OSTEOBLASTIC CELLS
Role of [Ca 2ϩ ] i on IL-6 and c-fos induction by PTHrP (107-139)
The possible involvement of [Ca 2ϩ ] i in IL-6 and c-fos gene induction by PTHrP (107-139) was also investigated in UMR 106 cells. Consistent with our previous findings in human osteoblastic cells (15) , this C-terminal PTHrP peptide (at 10 nm) increases IL-6 messenger RNA (mRNA) at 1 h in UMR 106 cells, an effect that was abolished by either verapamil or nifedipine (at 50 m) or 25 nm BIM, but not by 25 m RpcAMPS, a PKA inhibitor (37) (Fig. 9) .
Considering the inhibitory effects of PTHrP (107-139) on both cell growth and alkaline phosphatase in these cells (13, 16) , we hypothesized that this peptide would affect the expression of c-fos, a gene involved in the differentiation of these cells (38) . We found that PTHrP (107-139), at 10 nm, stimulates c-fos mRNA in UMR 106 cells within 1 h, but this effect was unaffected by 3 mm EGTA or 50 m verapamil, although it was inhibited by 6 nm BIM (Fig. 10) .
Discussion
PTHrP is thought to be an important factor in fetal and adult bone metabolism (9, 39) . A variety of studies indicate that the cAMP/PKA pathway coupled to PTH1R activation acts as a main regulator of osteoblastic differentiation (25, 40, 41) . In addition, the [Ca 2ϩ ] i /PKC signaling pathway, which is also associated with PTH1R activation, seems to modulate osteoblastic function either directly or interacting with cAMP synthesis in osteoblasts (1, 8, 25, 30, 41, 42) . Also, recent data suggest that the effects of PTHrP on bone metabolism might not only be mediated by interaction of its N-terminal domain with the PTH1R, but that other PTHrP regions also seem to be involved (13-19, 43, 44 ).
In the present study, PTHrP (1-36) triggered a dosedependent [Ca 2ϩ ] i response in cycling UMR 106 cells, consistent with previous findings using PTH or PTHrP (1-34) in these cells (5) (6) (7) (8) 26) . We found herein that PTHrP (107-139) also induced a [Ca 2ϩ ] i signal, characterized by both transient and sustained phases, which was more efficient than that observed with PTHrP (1-36) in these cells. Preincubation with the latter peptide or PTHrP (107-139) induced homologous, but not heterologous, [Ca 2ϩ ] i desensitization in these cells. Moreover, we found a synergistic effect of both peptides together at submaximal concentrations on Ca to that of PTHrP (1-36), depends on Ca 2ϩ influx through a voltage-sensitive Ca 2ϩ channel. In this regard, the three major isoforms of l-type Ca 2ϩ channels have been identified in osteoblastic cells, including UMR 106 cells (45) .
Our (26) . In this study, and in other studies using a similar approach, the [Ca 2ϩ ] i response to either PTH or PTHrP (1-34) was weak in these cells (5, 26) . Thus, the [Ca 2ϩ ] i response to either N-or C-terminal PTHrP in UMR 106 cells seems to require intercellular communication, as occurs when attached to coverslips (49, 50) .
The pattern of the [Ca 2ϩ ] i response to PTHrP (107-139) was found to be similar to that induced by PTHrP (107-111) in UMR 106 cells. In fact, similar effects of both peptides on cell proliferation and/or on several osteoblastic markers have previously been reported in these cells and in human osteoblastic cells (13, 14) . In this regard, the 107-111 epitope has been shown to mimic the inhibitory effect of PTHrP (107-139) on osteoblastic-mediated bone resorption, and also the effects of this peptide on keratinocyte proliferation and PKC activity (18 -21, 36, 44) . Furthermore, a recent study on the molecular structure of PTHrP (107-139), using nuclear magnetic resonance spectroscopy, has given credit to the hypothesis, based on current biological data, that the region 107-111 of this peptide would be responsible for its binding to a putative receptor (51) .
In the present study, we found that PTHrP (107-139) pretreatment enhanced the efficacy of the [Ca 2ϩ ] i response to PTHrP (52) . Moreover, the former but not the latter PTHrP peptide was shown to increase Ca 2ϩ influx even at 10 pm, the lowest dose tested (52). Our present results are consistent with, and establish a rationale to better understand, these previous findings. Previously, both endothelin and several prostaglandins have been shown to increase the [Ca 2ϩ ] i response to PTH in UMR 106 cells (5, 53 (54) . In fact, activation of the [Ca 2ϩ ] i /PKC pathway has been shown to modulate the response of IL-6 expression to various agonists in osteoblastic cells (23, 24) . PTHrP (107-139), within the same concentration range that maximally increases [Ca 2ϩ ] i in UMR 106 cells, stimulates IL-6 secretion in human osteoblastic cells, and this effect was abrogated by a PKC inhibitor (15) . These previous results and the present findings support a putative role of Ca 2ϩ influx in modulating IL-6 expression in osteoblastic cells. On the other hand, we found that PTHrP (107-139) rapidly induces c-fos mRNA, apparently dependent on PKC activation but not on [Ca 2ϩ ] i changes, in UMR 106 cells. This is consistent with the previously reported effects of this peptide on growth and differentiation (13, 16) , and the putative regulatory role of c-fos (38) , in these cells.
The effects of PTHrP (107-139) in osteoblastic cells reported herein might have pathophysiological significance. Thus, the actions of the N-terminal region of PTHrP could be modulated not only by other bone cytokines but also by the putative C-terminal fragment PTHrP (107-139) in the bone microenvironment. The present findings also support the notion that PTHrP, by interacting with the PTH1R and other yet unidentified receptors in bone cells, can regulate bone turnover through complex mechanisms.
